Skip navigation
MedlinePlus Trusted Health Information for You U.S. National Library of MedicineNational Institutes of Health
Contact Us FAQs Site Map About MedlinePlus
español Home Health Topics Drugs & Supplements Medical Encyclopedia Dictionary News Directories Other Resources
Printer-friendly versionEmail this page to a friend

Lyme disease - chronic persistent

Chronic persistent Lyme disease is a late stage of an inflammatory disease caused by Borrelia burgdorferi bacteria. It is also called Stage 3, or tertiary, Lyme disease.

See also:

Causes

Lyme disease is transmitted by the bite of a deer tick.

Some people may not be treated for Lyme disease because they do not have any symptoms or their symptoms are mild. Stage 3 Lyme disease may develop months or even years after the Lyme disease infection.

Even people who were treated may develop Stage 3 Lyme disease.

Symptoms

Chronic, or Stage 3 Lyme disease can affect the skin, brain, and nervous system, and muscles, bones, and cartilage.

Symptoms include:

Other symptoms that may occur with this disease:

Exams and Tests

A blood test can be done to check for antibodies to the bacteria that cause Lyme disease. The most common one used is the ELISA for Lyme disease test. A Western blot test is done to confirm ELISA results.

A spinal tap will be abnormal if you have central nervous system symptoms from the disease.

Treatment

Antibiotics are given to fight the infection. Medications sometimes need to be given through a vein (intravenously).

Stage 3 Lyme disease is treated for up to 28 days with antibiotics. If arthritis symptoms do not go away, a second 2 - 4 week course of antibiotics may sometimes be used. Antibiotics given by mouth (doxycycline, amoxicillin, or cefuroxime) are used most of the time.

A 2 - 4 week course of intravenous ceftriaxone may be used for treating severe Lyme disease that affects the nervous system.

Treating patients for longer periods of time is generally not thought to be helpful, even if symptoms do not go away.

Outlook (Prognosis)

Arthritis symptoms may not get better with treatment. Other symptoms should improve with treatment.

Rarely, a person will continue to have symptoms that can sometimes interfere with daily life or activities. Some people call this post-Lyme disease syndrome. There is no effective treatment for people with these symptoms.

Possible Complications

When to Contact a Medical Professional

Call your health care provider if you develop symptoms, especially if you have had Lyme disease before, or live or travel in high-risk areas.

Prevention

Early diagnosis and appropriate antibiotic treatment for primary Lyme disease is the most effective way to prevent tertiary Lyme disease.

Here are some tips for preventing primary Lyme disease:

When walking or hiking in wooded or grassy areas:

Check yourself and your pets frequently during and after your walk or hike.

Ticks that carry Lyme disease are so small that they are very hard to see. After returning home, remove your clothes and thoroughly inspect all skin surface areas, including your scalp.

If possible, ask someone to help you examine your body for ticks. Adults should carefully examine children.

Alternative Names

Tertiary Lyme disease; Stage 3 Lyme disease; Late persistent Lyme disease; Lyme arthritis

References

Bratton RL, Whiteside JW, Hoyan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008;83:566-571.

Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP. Ad Hoc International Lyme Disease Group. A critical appraisal of "chronic Lyme disease." N Engl J Med. 2007;357:1422-1430.

Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;69:91-102.

Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-1134.

Update Date: 3/17/2009

Updated by: Jatin M. Vyas, PhD, MD, Instructor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2009, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.


A.D.A.M. Logo